GlucoTrack Inc. (GCTK)
NASDAQ: GCTK
· Real-Time Price · USD
0.17
-0.01 (-3.02%)
At close: May 02, 2025, 3:59 PM
0.18
5.63%
After-hours: May 02, 2025, 05:56 PM EDT
Company Description
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally.
It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.
The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021.
GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
GlucoTrack Inc.
| Country | IL |
| IPO Date | Apr 25, 2013 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 11 |
| CEO | Paul V. Goode Ph.D. |
Contact Details
Address: 8 Ariel Sharon Street Or Yehuda, IL | |
| Website | https://www.glucotrack.com |
Stock Details
| Ticker Symbol | GCTK |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001506983 |
| CUSIP Number | 45824Q507 |
| ISIN Number | US45824Q5071 |
| Employer ID | 98-0668934 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Paul V. Goode Ph.D. | Chief Executive Officer, President & Director |
| Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board |
| David Malka BA | Co-Founder |
| Drinda Benjamin | Vice President of Marketing |
| Vincent Wong | Vice President of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 29, 2025 | 8-K | Current Report |
| Apr 28, 2025 | ARS | Filing |
| Apr 28, 2025 | DEF 14A | Filing |
| Apr 18, 2025 | PRE 14A | Filing |
| Apr 16, 2025 | 8-K | Current Report |
| Apr 04, 2025 | 8-K | Current Report |
| Apr 03, 2025 | 8-K | Current Report |
| Mar 31, 2025 | 10-K | Annual Report |
| Mar 31, 2025 | 8-K | Current Report |
| Mar 31, 2025 | 4 | Filing |